The incidence of permanent work disability in patients with rheumatoid arthritis in Sweden 1990-2010: before and after introduction of biologic agents
Open Access
- 16 November 2011
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 51 (2) , 338-346
Abstract
Objective. To explore the incidence of disability pension (DP) due to RA as an estimation of permanent work disability before and after introduction of biologic drugs. Methods. The annual incidence of DP was derived from the Swedish National Social Insurance Register and rates of DP due to RA were compared with the total amount of new DPs. Results.The incidence of DP due to RA has decreased over recent years, coinciding with earlier and more aggressive treatment with DMARDs and biologics. A similar declining incidence of DP was simultaneously seen in patients with all diagnoses in the general population. The decrease in DPs was, however, larger for RA and was evident even before introduction of biologics. In 1990, the proportion of DPs caused by RA was 1.9% out of total amount of DPs, decreasing to 1.5% in 2000 and to 1% in 2009. This may reflect effects of treatment, but may also be due to changing political policies as well as changes in age structure, increasing educational level and less physically demanding jobs. Conclusion. The decrease in DPs due to RA coincides with new treatment strategies as well as with decreasing levels of DPs in patients with all diagnoses. Prevailing political and economic conditions have a large impact on permanent work disability and may affect patients with various diagnoses in different ways. To determine if the decline is a true effect of better treatment, there is a need for further investigations, taking possible confounding factors into account.Keywords
This publication has 33 references indexed in Scilit:
- Decrease in the incidence of total hip arthroplasties in patients with rheumatoid arthritis - results from a well defined population in south SwedenArthritis Research & Therapy, 2011
- Decrease in sick leave among patients with rheumatoid arthritis in the first 12 months after start of treatment with tumour necrosis factor antagonists: a population-based controlled cohort studyAnnals of the Rheumatic Diseases, 2010
- Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008Rheumatology, 2010
- Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA StudyArthritis Research & Therapy, 2010
- Impact of adalimumab on work participation in rheumatoid arthritis: comparison of an open-label extension study and a registry-based control groupAnnals of the Rheumatic Diseases, 2009
- Comparison of work disability and health‐related quality of life between males and females with rheumatoid arthritis below the age of 45 yearsScandinavian Journal of Rheumatology, 2009
- Evaluation of the effect of anti–tumor necrosis factor agent use on rheumatoid arthritis work disability: The jury is still outArthritis Care & Research, 2008
- Neutrophilic myositis as a manifestation of celiac disease: a case reportClinical Rheumatology, 2008
- Pharmacoeconomic study of patients with chronic inflammatory joint disease before and during infliximab treatmentAnnals of the Rheumatic Diseases, 2006
- Living with rheumatoid arthritis: expenditures, health status, and social impact on patientsAnnals of the Rheumatic Diseases, 2002